
Class of receptors may be precisely targeted by drug compounds.

Class of receptors may be precisely targeted by drug compounds.

The latest news in oncology treatment research.

Some complementary or alternative medications can have an adverse reaction mixed with cancer drugs.

Biologic therapy targets genetic defects found in various cancers.

Baked potato extract found to suppress the spread of colon cancer stem cells.

Study shows nitroglycerin may improve the delivery of anticancer drugs.

Obesity leads to biomechanical changes that create the right conditions for tumor growth.

Varubi prevents nausea and vomiting associated with vomit-inducing cancer chemotherapy.

Cancer therapy filgrastim-sndz (Zarxio) was initially approved on March 6, 2015.

Oncologists will now be able to measure progress in cancer treatments.

Addition of docetaxel had the greatest benefit in patients with a high burden of metastatic disease.

The first biosimilar to receive FDA approval is now available the United States.

Genentech official sheds light on the current cancer drug pipeline.

Findings could lead to effective new cancer treatments.

Findings may lead to safer cancer treatments without side effects harmful to the brain.

Protein may hold key to eradicating cancer cells.

Afatinib treats patients with advanced squamous cell carcinoma of the lung that progressed after chemotherapy.

Long-term aspirin use may lessen colorectal cancer risk.

Link found between race and breast cancer life expectancy.

Dogs show promise in sniffing out melanoma, bladder, lung, breast, and ovarian cancers.

Policy may mitigate inaccurate perceptions of safety and efficacy for biological products.

Nanotechnology may lead to breakthroughs in the treatment of several diseases.

A significant increase in breast cancer development was found among a specific subset of women.

Recent developments in cancer treatment and research.

Beta-blockers found reduce to stress from hormones that fuel disease progression.

Study may help improve early cancer detection.

Study estimates United States is wasting $45 million every month that biosimilar Zarxio is not on the market.

Blocking oxygen sensor may improve colorectal cancer treatment.

Cancer drug may benefit patients with specific genetic mutation.

Researchers evaluate how PTEN protein regulates cell growth and how mutations can lead to cancer.